The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
Open accessAbstract
Colorectal cancer (CRC) is a common malignancy with high morbidity and mortality worldwide. To date, chemotherapy plays an important role in the treatment of CRC patients. Multidrug resistance (MDR) is one of the major hurdles in chemotherapy for CRC, and the underlying mechanisms need to be explored. Studies have demonstrated that Wnt/β‐catenin signaling plays a critical role in oncogenesis and tumor development, and its function in inhibiting apoptosis could facilitate tumor chemoresistance. Recent investigations have also suggested the regulatory effects of the Wnt/β‐catenin signaling pathway in response to chemotherapeutic agents in CRC. Here, we particularly focus on reviewing the evidences suggesting the mechanisms of Wnt/β‐catenin signaling in the chemoresistance modulation of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current studies have shown that activation of the Wnt/β-catenin signaling pathway can mediate CRC resistance to chemotherapy through several pathways, such as upregulation of MDR1, inhibition of apoptosis, maintenance of stem cell dryness, regulation of epithelial-mesenchymal transformation (EMT) and regulation of tumor microenvironment [191].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Li, T., Guo, H., Song, Y., Zhao, X., Shi, Y., Lu, Y., Hu, S., Nie, Y., Fan, D., & Wu, K. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-263 · Cited by 82 · cited 10×
“It has been proven that Wnt/β-catenin signaling modulates the expression of CSC marker genes and plays a role in the self-renewal ability and undifferentiated status of CSCs [43–45].”
BackgroundInfluentialRetractedDermani, F. K., Amini, R., Saidijam, M., Pourjafar, M., Saki, S., & Najafi, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26874 · Cited by 45 · cited 1×
“It was also observed that zerumbone could suppress the stemness properties of CRC by inhibiting the β-catenin signaling pathway [52].”
BackgroundRetractedMiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
Fan, H., Liu, X., Zheng, W.-W., Zhuang, Z.-H., & Wang, C.-D. (2017) · PubMed · doi:10.26355/eurrev_202007_22181 · Cited by 26 · cited 1×
“They have been increasingly implicated in the regulation of cell stemness and EMT, which contribute to drug resistance in colorectal cancer [83, 84].”
BackgroundRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 1×
“Colorectal cancer (CRC), one of the most prevalent malignancies, ranked third in cancer incidence in both genders and remains the second cause of cancer-related deaths in the world [1].”
BackgroundThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“In CRC, loss of E-cadherin is concomitant with the deregulation of the Wnt/β-catenin signaling pathway and has been characterized as a trait of EMT cells [71].”
BackgroundThe Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672 · cited 1×
“differentiate into heterogeneous cell lineages that constitute the tumor [34, 35].”
BackgroundComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · cited 2×
“Wnt/β-catenin signaling pathway is found altered in more than 90% CRC patients, making it a crucial therapeutic target [11].”
BackgroundEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628 · cited 1×
“EMT is a process that allows epithelial cells to undergo remarkable morphologic changes to assume a migratory mesenchymal phenotype characterized by loss of apical basolateral polarity and cell-cell adhesion [56, 57].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958 · cited 2×
“As one of the major signaling pathways involved in EMT, Wnt/β-catenin signaling converging on activation of transcription factors such as ZEB and Snail was triggered to induce the expression of mesenchymal genes and repress E-cadherin expression [57, 66].”
BackgroundSnail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“As one of the major signaling pathways involved in EMT, Wnt/β-catenin signaling converging on activation of transcription factors such as ZEB and Snail was triggered to induce the expression of mesenchymal genes and repress E-cadherin expression [57, 66].”
BackgroundEMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389 · cited 1×
“Chemotherapeutic strategies that kill bulks of tumor cells may fail at last, partly because they fail to eliminate CSCs and then result in the relapse of tumors [39].”
BackgroundWnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804 · cited 1×
“In stromal cells, it is reported that hepatocyte growth factor (HGF) secreted by myofibroblasts could activate nuclear β-catenin activity and thereby affect stemness features which are associated with chemoresistance in colorectal cancer cells [75].”
BackgroundFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · cited 1×
“Nevertheless, the underlying mechanism was not related to the β-catenin signaling pathway [80, 81].”
BackgroundThe Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Plaks, V., Kong, N., & Werb, Z. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.015 · Cited by 1,557 · cited 1×
“Nevertheless, the underlying mechanism was not related to the β-catenin signaling pathway [80, 81].”
BackgroundByers, L. A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1558 · Cited by 1,059
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
Ruiz de Galarreta, M., Bresnahan, E., Molina-Sánchez, P., Lindblad, K. E., Maier, B., Sia, D., Puigvehi, M., Miguela, V., Casanova-Acebes, M., Dhainaut, M., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0074 · Cited by 912 · cited 2×
“Active forms of β-catenin promote resistance to immunotherapy with anti-PD-1, which impairs T-cell activity and involves the deficient recruitment of DCs [79].”
BackgroundEpithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H., Marquis, L., Abbruzzese, J. L., Gallick, G. E., Logsdon, C. D., McConkey, D. J., & Choi, W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2819 · Cited by 863
Ren, J., Ding, L., Zhang, D., Shi, G., Xu, Q., Shen, S., Wang, Y., Wang, T., & Hou, Y. (2018) · Theranostics · doi:10.7150/thno.25541 · Cited by 698 · cited 2×
“In colorectal cancer, CAFs could promote drug resistance by transferring exosomal H19, which activates the β-catenin signaling pathway via acting as a competing endogenous RNA sponge [76].”
BackgroundKurrey, N. K., Jalgaonkar, S. P., Joglekar, A. V., Ghanate, A. D., Chaskar, P. D., Doiphode, R. Y., & Bapat, S. A. (2009) · Stem Cells · doi:10.1002/stem.154 · Cited by 655
Lu, Z., Ghosh, S., Wang, Z., & Hunter, T. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00304-0 · Cited by 647 · cited 1×
“β-Catenin and Ecadherin form a complex in the area of cell–cell junction, providing the basis for cell–cell association [67].”
BackgroundDrug Resistance Driven by Cancer Stem Cells and Their Niche
Prieto-Vila, M., Takahashi, R.-U., Usuba, W., Kohama, I., & Ochiya, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122574 · Cited by 508 · cited 1×
“The occurrence of EMT was proven to be closely associated with the activation of intracellular stem-associated pathways including Wnt/β-catenin, Notch, TGF-β, and Hedgehog pathways while the underlying mechanisms have not been clearly defined [64, 65].”
BackgroundTargeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Takahashi-Yanaga, F., & Kahn, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2943 · Cited by 499
Han, P., Li, J.-W., Zhang, B.-M., Lv, J.-C., Li, Y.-M., Gu, X.-Y., Yu, Z.-W., Jia, Y.-H., Bai, X.-F., Li, L., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0583-1 · Cited by 496
Apoptosis and APC in colorectal tumorigenesis.
Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7950 · Cited by 489 · cited 1×
“As a tumor suppressor protein, APC could induce cell death of CRC through apoptosis in CRC [27].”
BackgroundMultiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis
Donnenberg, V. S., & Donnenberg, A. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005276905 · Cited by 457 · cited 1×
“Since CSCs express MDR1 intrinsically and own advantages in enhanced DNA repair capacity as well as high antiapoptotic signaling activation, they are also thought to be closely related to tumor chemoresistance [37].”
BackgroundZhang, T., Otevrel, T., Gao, Z., Gao, Z., Ehrlich, S. M., Fields, J. Z., & Boman, B. M. (2001) · PubMed · Cited by 441
Lu, Y., Zhao, X., Liu, Q., Li, C., Graves-Deal, R., Cao, Z., Singh, B., Franklin, J. L., Wang, J., Hu, H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4424 · Cited by 425 · cited 1×
“Cetuximab Repress multiple Wnt negative regulators and increase Wnt signaling DKK1 and DKK3 [90]”
BackgroundA combinatorial strategy for treating KRAS-mutant lung cancer
Manchado, E., Weissmueller, S., Morris, J. P., Chen, C.-C., Wullenkord, R., Lujambio, A., de Stanchina, E., Poirier, J. T., Gainor, J. F., Corcoran, R. B., et al. (2016) · Nature · doi:10.1038/nature18600 · Cited by 403
WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription
Chen, S., Guttridge, D. C., You, Z., Zhang, Z., Fribley, A., Mayo, M. W., Kitajewski, J., & Wang, C.-Y. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.1.87 · Cited by 394 · cited 1×
“As a member of Wnt proteins initiating the canonical Wnt signaling pathway, Wnt1 inhibits apoptosis of colorectal cancer cells through blocking the caspase-9 activation induced by chemotherapeutic drugs, and this sensitivity to apoptotic stimuli could be blocked by inhibiting β-catenin/TCF transcription [24].”
BackgroundColorectal Cancer Stem Cells: From the Crypt to the Clinic
Zeuner, A., Todaro, M., Stassi, G., & De Maria, R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.012 · Cited by 368 · cited 2×
“Moreover, studies have proven that EMT is a crucial way to induce CSC formation in many tumors, and induction of EMT confers properties of self-renewing stem cells, suggesting a close relation between EMT and the acquisition of stem cell characteristics [36, 58, 59].”
BackgroundBiddle, A., Liang, X., Gammon, L., Fazil, B., Harper, L. J., Emich, H., Costea, D. E., & Mackenzie, I. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1059 · Cited by 356 · cited 1×
“Moreover, studies have proven that EMT is a crucial way to induce CSC formation in many tumors, and induction of EMT confers properties of self-renewing stem cells, suggesting a close relation between EMT and the acquisition of stem cell characteristics [36, 58, 59].”
BackgroundCancer stem cells – old concepts, new insights
Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G., & Medema, J. P. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.20 · Cited by 352 · cited 1×
“differentiate into heterogeneous cell lineages that constitute the tumor [34, 35].”
BackgroundMa, Y., Yang, Y., Wang, F., Moyer, M.-P., Wei, Q., Zhang, P., Yang, Z., Liu, W., Zhang, H., Chen, N., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308392 · Cited by 304 · cited 3×
“The MDR1 gene promoter was found to contain many T-cell factor 4- (TCF4-) binding sequences, and this gene was demonstrated to be transcriptionally downregulated after TCF4 inactivation in CRC, suggesting MDR1 is a direct target of the TCF4/βcatenin transcriptional complex [18].”
BackgroundMicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells
Hwang, W.-L., Jiang, J.-K., Yang, S.-H., Huang, T.-S., Lan, H.-Y., Teng, H.-W., Yang, C.-Y., Tsai, Y.-P., Lin, C.-H., Wang, H.-W., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2910 · Cited by 304 · cited 2×
“They have been increasingly implicated in the regulation of cell stemness and EMT, which contribute to drug resistance in colorectal cancer [83, 84].”
BackgroundYamada, T., Takaoka, A., Naishiro, Y., Hayashi, R., Maruyama, K., Maesawa, C., Ochiai, A., & Hirohashi, S. (2000) · PubMed · Cited by 285
Wang, H., Wang, H.-S., Zhou, B.-H., Li, C.-L., Zhang, F., Wang, X.-F., Zhang, G., Bu, X.-Z., Cai, S.-H., & Du, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056664 · Cited by 273
Barr, M. P., Gray, S. G., Hoffmann, A. C., Hilger, R. A., Thomale, J., O’Flaherty, J. D., Fennell, D. A., Richard, D., O’Leary, J. J., & O’Byrne, K. J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233739 · Cited by 269
Multidrug resistance: Physiological principles and nanomedical solutions
Kunjachan, S., Rychlik, B., Storm, G., Kiessling, F., & Lammers, T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.018 · Cited by 259
Wnt signaling in stem and cancer stem cells
Wend, P., Holland, J. D., Ziebold, U., & Birchmeier, W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.004 · Cited by 237 · cited 1×
“Accumulating evidences suggest that the Wnt/βcatenin signaling pathway, which regulates normal stem cell differentiation and proliferation, is important in maintaining cancer stem cell properties [46, 47].”
BackgroundColon cancer: Cancer stem cells markers, drug resistance and treatment
Kozovska, Z., Gabrisova, V., & Kucerova, L. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.019 · Cited by 228 · cited 1×
“In colorectal cancer, several stem cell markers including Bmi1, Nanog, and CD44 have been identified, proving the existence of CSCs in CRC [41, 42].”
BackgroundRenal Drug Transporters and Drug Interactions
Ivanyuk, A., Livio, F., Biollaz, J., & Buclin, T. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0506-8 · Cited by 221 · cited 1×
“One of the most typical mechanisms of MDR is that ABC membrane transporters pump various chemotherapeutic agents out of cells to reduce intracellular drug accumulation and attenuate drug-induced cytotoxicity [11, 12].”
BackgroundTalbot, L. J., Bhattacharya, S. D., & Kuo, P. C. (2012) · Europe PMC (PubMed Central) · Cited by 219
Deng, X., Ruan, H., Zhang, X., Xu, X., Zhu, Y., Peng, H., Zhang, X., Kong, F., & Guan, M. (2020) · International Journal of Cancer · doi:10.1002/ijc.32608 · Cited by 218
Self-citationChemoresistance and the Self-Maintaining Tumor Microenvironment
Yeldag, G., Rice, A., & Del Río Hernández, A. (2018) · Cancers · doi:10.3390/cancers10120471 · Cited by 214 · cited 2×
“As the main component of the stroma, cancer-associated fibroblasts (CAFs), different from normal fibroblasts in the TME, exert inherent support on cancer cells via secretion of molecular messengers and cell-to-cell contact [74].”
BackgroundRationally designed nanovehicles to overcome cancer chemoresistance
Livney, Y. D., & Assaraf, Y. G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.006 · Cited by 205 · cited 1×
“These transporters could pump out chemotherapeutic agents and reduce the accumulation of intracellular drugs, leading to an impairment of chemotherapeutic effects [5, 6].”
BackgroundHo, G.-T., Moodie, F. M., & Satsangi, J. (2003) · Gut · doi:10.1136/gut.52.5.759 · Cited by 204 · cited 1×
“P-Glycoprotein (P-gp), referred to as MDR1 (multidrug resistance protein 1) or ABCB1 (ATP-binding cassette subfamily B, member 1), is the most crucial ABC transporter in human gastrointestinal system [14, 15].”
BackgroundClinical relevance of colorectal cancer molecular subtypes
Rodríguez-Salas, N., Dominguez, G., Barderas, R., Mendiola, M., García‐Albéniz, X., Maurel, J., & Batlle, J. F. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.007 · Cited by 170 · cited 1×
“Previous studies have identified the Wnt/β-catenin signaling pathway as a key pathway involved in various processes of CRC [9].”
BackgroundWnt/β-catenin Signaling in Normal and Cancer Stem Cells
Valkenburg, K. C., Graveel, C. R., Diegel, C. R., Zhong, Z. A., & Williams, B. O. (2011) · Cancers · doi:10.3390/cancers3022050 · Cited by 169
Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights
Farooqi, A. A., de la Roche, M., Djamgoz, M. B. A., & Siddik, Z. H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.01.001 · Cited by 163 · cited 1×
“The most common genetic changes accompanying CRC progression are mutations that deregulate the Wnt/β-catenin signaling cascade [7].”
BackgroundKitai, H., Ebi, H., Tomida, S., Floros, K. V., Kotani, H., Adachi, Y., Oizumi, S., Nishimura, M., Faber, A. C., & Yano, S. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1377 · Cited by 162
Human tumor nanoparticles induce apoptosis of pancreatic cancer cells
Ristorcelli, E., Béraud, E., Verrando, P., Villard, C., Lafitte, D., Sbarra, V., Lombardo, D., & Vérine, A. (2008) · The FASEB Journal · doi:10.1096/fj.07-102855 · Cited by 157 · cited 1×
“As a serine threonine kinase, GSK3β could constitutively phosphorylate β-catenin and serve as a negative regulator of the Wnt/β-catenin signaling pathway [25].”
BackgroundXiao, Z., Qu, Z., Chen, Z., Fang, Z., Zhou, K., Huang, Z., Guo, X., & Zhang, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489110 · Cited by 157 · cited 1×
“lncRNA HOTAIR Colo205 and SW620 cells Cisplatin, paclitaxel Promote the chemoresistance of CRC cells through targeting miR-203a-3p-mediated Wnt/β-catenin signaling pathway miR-203a-3p [92] 5 BioMed Research International”
BackgroundSelf-citationATP-binding cassette transporters in reproduction: a new frontier.
Bloise, E., Ortiga-Carvalho, T., Reis, F., Lye, S., Gibb, W., & Matthews, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv049 · Cited by 143 · cited 2×
“Multidrug resistance is a major impediment to successful treatment of CRC, and overcoming MDR becomes a great challenge in fighting against CRC [5].”
BackgroundChen, H., Yuan, K., Xie, N., Wang, K., Huang, Z., Chen, Y., Dou, Q., Wu, M., Nice, E. C., Zhou, Z., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1962 · Cited by 131 · cited 2×
“[72] showed that nuclear translocation of membrane β-catenin and disassociation of the E-cadherin/β-catenin complex activate β-catenin–TCF transcription, decrease E-cadherin levels, and increase Snail expression.”
BackgroundQi, L., Sun, B., Liu, Z., Cheng, R.-F., Li, Y., & Zhao, X. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0107-4 · Cited by 128 · cited 1×
“[73] demonstrated that Wnt3a overexpression leads to the distribution of cytosolic β-catenin, downregulation of epithelial markers, and overexpression of mesenchymal markers, in both cellular and animal models of colorectal cancer.”
BackgroundMicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity
Hollis, M. V. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i27.8284 · Cited by 128 · cited 1×
“, miR-192, miR-587, miR-133a, miR-215, and miR-492) are associated with increased chemoresistance in CRC [85].”
BackgroundSu, Y., & Simmen, F. A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn279 · Cited by 128 · cited 1×
“For example, as a soy-derived isoflavone, which could be used as an inhibitor of the Wnt pathway by inactivating β-catenin signaling through overexpressing GSK3β and E-cadherin, Genistein has been reported to play a role in reversing resistance to fluoropyrimidine compounds and platinum [93].”
BackgroundWu, X., LUO, F., LI, J., Zhong, X., & Liu, K. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3360 · Cited by 120 · cited 1×
“Previous evidence showed that inhibition of Wnt/β-catenin signaling by the inhibitor XAV939 could significantly increase the apoptosis induced by 5-FU in colon cancer cells [22].”
BackgroundGurzu, S., Silveanu, C., Fetykó, A., Butiurcă, V. O., Kovács, Z., & Jung, I. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6764 · Cited by 112
The Network of Non-coding RNAs in Cancer Drug Resistance
Corrà, F., Agnoletto, C., Minotti, L., Baldassari, F., & Volinia, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00327 · Cited by 111 · cited 1×
“In recent years, an increasing number of studies have indicated that regulation of gene expression by various noncoding RNAs (ncRNAs) such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) were involved in the acquisition of chemoresistance after treatment [82].”
BackgroundWang, T., Chen, Z., Zhu, Y., Pan, Q., Liu, Y., Qi, X., Jin, L., Jin, J., Ma, X., & Hua, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.590364 · Cited by 104 · cited 1×
“[21] also demonstrated that suppressing TrpC5 expression could reverse 5-FU resistance in colorectal cancer by weakening the ABCB1 efflux pump through inhibiting the canonical Wnt/β-catenin signaling pathway.”
BackgroundZhou, H., Lin, C., Zhang, Y., Zhang, X., Zhang, C., Zhang, P., Xie, X., & Ren, Z. (2017) · Cell Proliferation · doi:10.1111/cpr.12341 · Cited by 98 · cited 12×
“In the Wnt/β-catenin signaling cascade, nuclear βcatenin could preferentially recruit CBP to the promoter region of MDR1 gene, and MDR1 has been proven to be one of the target genes of TCF/LEF [16, 17].”
BackgroundInfluentialSelf-citationMASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
Uppada, S. B., Gowrikumar, S., Ahmad, R., Kumar, B., Szeglin, B. C., Chen, X., Smith, J. J., Batra, S. K., Singh, A. B., & Dhawan, P. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0848-3 · Cited by 86 · cited 1×
“MASTL induces resistance to 5-fluorouracil (5-FU) through regulating antiapoptotic proteins survivin and Bcl-xL via the Wnt/β-catenin signaling pathway [33].”
BackgroundAlmendro, V., Ametller, E., García‐Recio, S., Collazo, O., Casas, I., Auge, J. M., Maurel, J., & Gascón, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004728 · Cited by 86 · cited 1×
“For instance, MMP-7 could increase the oxaliplatin resistance of colon cancer cells by decreasing the Fas receptor that promotes cell apoptosis [28].”
BackgroundWang, Y., Zhang, Y., Zhang, G.-N., Rihani, S. B. A., Wei, M.-N., Gupta, P., Zhang, X., Shukla, S., Ambudkar, S. V., Kaddoumi, A., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.011 · Cited by 83
Self-citationPandurangan, A. K., Dharmalingam, P., Anandasadagopan, S. K., Ramar, M., Arumugam, M., & Ganapasam, S. (2013) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2013007522 · Cited by 78 · cited 1×
“Similar results were also observed in Chinese medicine including luteolin and Sanguisorba officinalis which could induce apoptosis by enhancing the Bax and caspase-3 expression and suppressing Bcl-2 expression through Wnt/β-catenin signaling in CRC cell lines [31, 32].”
ResultLee, M. A., Park, J., Rhyu, S. Y., Oh, S., Kang, W.-K., & Kim, H.-N. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-125 · Cited by 77 · cited 1×
“Wnt/β-catenin signaling pathway, essential for maintaining cell homeostasis and embryonic development, was demonstrated to be associated with tumor cell proliferation, apoptosis, invasion, stemness, and chemotherapy resistance [8] (Figure 1).”
BackgroundJiang, S., Miao, D., Wang, M., Lv, J., Wang, Y., & Tong, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13968 · Cited by 76 · cited 1×
“miR-30-5p CD133+CRC cells (Caco2 and HCT15) 5-FU Inhibit CRC cell stemness and chemoresistance through USP22/Wnt/β-catenin signaling axis USP22 [88]”
BackgroundTargeting the Wnt signaling pathway in colorectal cancer
Sawa, M., Masuda, M., & Yamada, T. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1098619 · Cited by 73 · cited 1×
“It has been proven that CSCs display resistance to chemotherapeutic drugs through overexpressing ATP-binding cassette- (ABC-) family transporters, which act as drug-efflux pumps [40].”
BackgroundTepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
Wu, Z., Teng, Q., Cai, C., Wang, J., Lei, Z., Yang, Y., Fan, Y., Zhang, J., Li, J., & Chen, Z. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.05.015 · Cited by 73 · cited 1×
“Most of the ABC transporters contribute directly to chemoresistance, and attenuating their efflux activity could significantly reverse the resistance [13].”
BackgroundOnyido, E. K., Sweeney, E., & Nateri, A. S. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0541-3 · Cited by 71 · cited 1×
“Recent advance to date have strongly cemented the fact that lncRNAs could modulate the chemoresistance of CRC through miRNAs, and miRNAs could crosstalk with various key cellular signaling networks including the Wnt/β-catenin cascade [86, 87].”
BackgroundBaur, A. S., Lutz, M. B., Schierer, S., Beltrame, L., Theiner, G., Zinser, E., Ostalecki, C., Heidkamp, G. F., Haendle, I., Erdmann, M., et al. (2013) · Blood · doi:10.1182/blood-2012-09-456988 · Cited by 64 · cited 1×
“In immune cell populations, a study showed that tumor-induced β-catenin signaling infiltrates immune effector cells into a tolerant state and inhibits the DCdependent cross-sensitization of antitumor CTLs [78].”
BackgroundYang, D., Zhang, X., Zhang, W., & Thamaraiselvan, R. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s149307 · Cited by 59 · cited 1×
“[29] reported that Vicenin-2 induces apoptosis in colon cancer by suppressing Bcl-2 and enhancing the expression of Bax and caspase-3 through Wnt/β-catenin signaling.”
BackgroundSelf-citationBianchi, A. S., Loupakis, F., Argilés, G., & Prager, G. W. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw191 · Cited by 58
LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer
Wang, L., Zhang, X., Li, S., Qiu, C., & Luo, R. (2018) · Bioscience Reports · doi:10.1042/bsr20180790 · Cited by 56 · cited 1×
“Recent advance to date have strongly cemented the fact that lncRNAs could modulate the chemoresistance of CRC through miRNAs, and miRNAs could crosstalk with various key cellular signaling networks including the Wnt/β-catenin cascade [86, 87].”
BackgroundSelf-citationZhang, G.-J., Li, L., Yang, G., Xia, S., Wang, R., Leng, Z., Liu, Z.-L., Tian, H., He, Y., Meng, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21667 · Cited by 55 · cited 1×
“miR-92a HT-29 and HCT116 cells 5-FU IL-6/STAT3/miR-92a/Wnt/β-catenin signaling pathway promotes stem-like phenotypes of colorectal cancer cells KLF4, GSK3β, and DKK3 [89]”
BackgroundLiu, D., Du, L., Chen, D., Ye, Z., Duan, H., Tu, T., Feng, J., Yang, Y., Chen, Q., & Yan, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9930 · Cited by 54 · cited 1×
“[51] showed that CD146 decreased the drug resistance of colorectal cancer by functioning as a suppressor of cancer stemness through inactivating the Wnt/β-catenin cascade.”
BackgroundHuang, G., Song, W., Zhou, P., Fu, Q., Lin, C.-L., Chen, Q., & Shen, D. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1295180 · Cited by 50 · cited 1×
“Moreover, RARg overexpression was shown to contribute to the multidrug resistance of CRC cells by upregulating MDR1 through activating the Wnt/β-catenin signaling pathway [20].”
BackgroundmiR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2
Chen, H., Lang, Y., Lin, H.-N., Liu, Y., Liao, C.-C., Nana, A. W., Yen, Y., & Chen, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-41053-z · Cited by 48
Feng, S., Zheng, Z., Feng, L., Yang, L., Chen, Z., Lin, Y., Gao, Y., & Yide, C. (2016) · Oncology Reports · doi:10.3892/or.2016.5154 · Cited by 47 · cited 2×
“Moreover, studies have proven that EMT is a crucial way to induce CSC formation in many tumors, and induction of EMT confers properties of self-renewing stem cells, suggesting a close relation between EMT and the acquisition of stem cell characteristics [36, 58, 59].”
BackgroundDewi, F. R. P., Domoto, T., Hazawa, M., Kobayashi, A., Douwaki, T., Minamoto, T., & Wong, R. W.-C. (2018) · Oncotarget · doi:10.18632/oncotarget.24344 · Cited by 40 · cited 1×
“[26] showed that inhibition of GSK3β could increase the apoptosis of CRC cells.”
BackgroundUrushibara, S., Tsubota, T., Asai, R., Azumi, J., Ashida, K., Fujiwara, Y., & Shiota, G. (2017) · Anticancer Research · doi:10.21873/anticanres.11795 · Cited by 34
Huynh, N. T., Shulkes, A., Baldwin, G. S., & He, H. Z. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1195045 · Cited by 32 · cited 1×
“In colorectal cancer, several stem cell markers including Bmi1, Nanog, and CD44 have been identified, proving the existence of CSCs in CRC [41, 42].”
BackgroundLi, W., Yang, C., Wang, L.-Q., Wu, J., Dai, C., Yuan, Y., Li, G. Q., & Yao, M. (2019) · Chinese Medicine · doi:10.1186/s13020-019-0244-y · Cited by 27 · cited 1×
“Similar results were also observed in Chinese medicine including luteolin and Sanguisorba officinalis which could induce apoptosis by enhancing the Bax and caspase-3 expression and suppressing Bcl-2 expression through Wnt/β-catenin signaling in CRC cell lines [31, 32].”
ResultLi, Q., Yang, T., Li, D., Ding, F., Bai, G., Wang, W., & Sun, H. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0162 · Cited by 26 · cited 1×
“[30] demonstrated that silencing aquaporin-5 could enhance the sensitivity of CRC cells to 5-FU by inducing apoptosis through the Wnt/β-catenin signaling pathway.”
BackgroundMiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1
Fan, H., Liu, X., Zheng, W., Zhuang, Z., & Wang, C.-D. (2020) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 25
CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription
Xia, Z., Guo, M., Liu, H., Jiang, L., Li, Q., Peng, J., Li, J., Shan, B., Feng, P., & Ma, H. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150506093643 · Cited by 21 · cited 3×
“Downregulated cytoplasmic β-catenin recruits the corepressor Groucho to TCF/LEF, ensuring transcriptional repression and blocking the target genes from being activated.”
BackgroundTakahashi, H., Nakamura, K., Usami, A., Tsuruta, T., Hashimura, M., Matsumoto, T., & Saegusa, M. (2017) · Histopathology · doi:10.1111/his.13227 · Cited by 21 · cited 1×
“Moreover, accumulation of nuclear β-catenin enhances both the chemoresistance and radioresistance of locally advanced rectal cancer through regulating EMT/CSC properties, and nuclear β-catenin in pretreatment-biopsied samples is promising in predicting the efficacy of chemoradiotherapy in rectal cancer patients [50].”
BackgroundBarr, M. P., Gray, S. G., Hoffmann, A. C., Hilger, R. A., Thomale, J., O’Flaherty, J. D., Fennell, D. A., Richard, D., O’Leary, J. J., & O’Byrne, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054193 · Cited by 19 · cited 1×
“It has been reported that drug-resistant tumor cells display a stem-like signature [38].”
BackgroundYokogi, S., Tsubota, T., Kanki, K., Azumi, J., Itaba, N., Oka, H., Morimoto, M., Ryoke, K., & Shiota, G. (2016) · PubMed Central · Cited by 16
Cited by
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
“Studies have shown that Wnt/−catenin signaling plays a key role in tumorigenesis and tumor development, and its function of inhibiting cell apoptosis can promote tumor chemoresistance [38].”
BackgroundDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
DeRango-Adem, E. F., & Blay, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681477 · Cited by 126
“This pathway regulates cellular behaviors including migration and the formation of tissue structures, and plays a key role in both the formation and progression of cancers, including colorectal carcinoma (Yuan et al., 2020; Bugter et al., 2021; Caspi et al., 2021).”
BackgroundZhang, L., Li, C., & Su, X. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01784-8 · Cited by 96
Zhang, Q., Yang, X., Wu, J., Ye, S., Gong, J., Cheng, W. M., Luo, Z., Yu, J., Liu, Y., Zeng, W., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00515-x · Cited by 102
Metadata
- Authors
- Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X., & Wu, D.
- Affiliations
- Qingdao Municipal Hospital (CN)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wu, Dapeng
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 2020
- Issue
- 1
- Pages
- 9390878-9390878
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC7109575
- OpenAlex
- W3012199016
- Cited by
- 131
- References
- 94
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 17 · 2023: 22 · 2022: 26 · 2021: 21 · 2020: 9
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Science and Technology Commission of Qingdao Municipality (KJZD-13-39-JCH)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- Wnt/β-catenin signaling, colorectal cancer, chemoresistance, multidrug resistance, apoptosis inhibition, anticancer agents, carcinogenesis
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasm Proteins, Colorectal Neoplasms, Drug Resistance, Neoplasm, beta Catenin, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
